T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Zoom
ZM
|
+$2.88B |
| 2 |
Eli Lilly
LLY
|
+$2.63B |
| 3 |
AstraZeneca
AZN
|
+$1.96B |
| 4 |
Fortinet
FTNT
|
+$1.66B |
| 5 |
Coupang
CPNG
|
+$1.63B |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
+$2.58B |
| 2 |
Morgan Stanley
MS
|
+$2.29B |
| 3 |
Airbnb
ABNB
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.8B |
| 5 |
Qualcomm
QCOM
|
+$1.79B |
Sector Composition
| 1 | Technology | 23.37% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Marathon Petroleum
MPC
$55.2B
| $124M | 0.01% |
2,324,565
-7,711
| -0.3% | -$412K |
|
702
Medpace
MEDP
$13.4B
| $124M | 0.01% |
756,852
-24,021
| -3% | -$3.94M |
|
|
MODV
703
DELISTED
ModivCare
MODV
| $124M | 0.01% |
834,521
+139,879
| +20% | +$20.7M |
|
704
Virtus Investment Partners
VRTS
$1.31B
| $124M | 0.01% |
524,838
-11,011
| -2% | -$2.59M |
|
705
SLM Corp
SLM
$6.01B
| $124M | 0.01% |
6,873,988
-398,102
| -5% | -$7.15M |
|
706
Texas Roadhouse
TXRH
$11B
| $123M | 0.01% |
1,285,167
+143,573
| +13% | +$13.8M |
|
707
Douglas Emmett
DEI
$2.75B
| $123M | 0.01% |
3,922,615
-377,934
| -9% | -$11.9M |
|
708
Quanterix
QTRX
$201M
| $123M | 0.01% |
2,103,054
+817,697
| +64% | +$47.8M |
|
709
Allogene Therapeutics
ALLO
$246M
| $122M | 0.01% |
3,456,753
-103,040
| -3% | -$3.64M |
|
|
ALXN
710
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $121M | 0.01% |
792,319
-743,854
| -48% | -$114M |
|
711
Surgery Partners
SGRY
$2.75B
| $121M | 0.01% |
2,723,997
+2,716,573
| +36,592% | +$120M |
|
|
CSW
712
CSW Industrials, Inc.
CSW
$4.24B
| $120M | 0.01% |
889,787
+228,559
| +35% | +$30.9M |
|
713
Teck Resources
TECK
$19.8B
| $120M | 0.01% |
6,241,219
+5,538,688
| +788% | +$106M |
|
714
Valmont Industries
VMI
$7.45B
| $119M | 0.01% |
501,731
+136,554
| +37% | +$32.5M |
|
715
Apple Hospitality REIT
APLE
$2.97B
| $119M | 0.01% |
8,182,617
+3,013,971
| +58% | +$43.9M |
|
716
Celanese
CE
$4.84B
| $119M | 0.01% |
794,795
+127,810
| +19% | +$19.1M |
|
717
Manulife Financial
MFC
$52.4B
| $119M | 0.01% |
5,531,859
+7,855
| +0.1% | +$169K |
|
718
Twist Bioscience
TWST
$1.46B
| $119M | 0.01% |
957,907
-13,070
| -1% | -$1.62M |
|
719
Pacific Biosciences
PACB
$366M
| $118M | 0.01% |
3,540,299
+221,559
| +7% | +$7.38M |
|
720
Hanesbrands
HBI
$2.21B
| $118M | 0.01% |
5,976,850
-129,566
| -2% | -$2.55M |
|
721
Acadia Realty Trust
AKR
$2.54B
| $117M | 0.01% |
6,188,123
-729,526
| -11% | -$13.8M |
|
722
CarMax
KMX
$8.88B
| $117M | 0.01% |
882,372
-3,606,944
| -80% | -$478M |
|
723
Tyler Technologies
TYL
$23.6B
| $117M | 0.01% |
274,720
-68,387
| -20% | -$29M |
|
724
First Industrial Realty Trust
FR
$6.77B
| $116M | 0.01% |
2,541,928
-996,804
| -28% | -$45.6M |
|
725
Carpenter Technology
CRS
$12.3B
| $116M | 0.01% |
2,819,722
+34,558
| +1% | +$1.42M |
|